Skip to main navigation

Fate Therapeutics

0
Skip to content
  • About Us
    • Our Mission
    • Our Cells of Interest
    • Management
    • Board of Directors
  • Pipeline
    • Overview
    • Immuno-Oncology Candidates
      • FT500
      • FT516
      • FT596
      • FT538
      • FT576
      • FT819
    • Immuno-Regulation Candidates
      • ProTmune™
      • FT301
  • Science
    • Ex Vivo Cell Modulation
    • iPSC Platform
    • Manufacturing
    • Publications
  • Collaborations
  • Join Our Team
    • Career Opportunities
    • Vision, Mission, Values
    • Working at Fate
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
      • Historic Stock Lookup
    • Investors FAQs
  • Contact
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial & Filings
    • Corporate Governance
    • Stock Information
    • Investors FAQs

Download Library

Document Type
2021 Annual Report 2.1 MB
2021 Annual Report 2.1 MB
2020 Annual Report 1.1 MB
2020 Annual Report 1.1 MB
2019 Annual Report 1.1 MB
2019 Annual Report 1.1 MB
2018 Annual Report 9.6 MB
2018 Annual Report 9.6 MB
2017 Annual Report 4 MB
2017 Annual Report 4 MB
2016 Annual Report 4.7 MB
2016 Annual Report 4.7 MB
2015 Annual Report 998.1 KB
2015 Annual Report 998.1 KB
2014 Annual Report 7 MB
2014 Annual Report 7 MB
Audit Committee Charter 52.7 KB
Audit Committee Charter 52.7 KB
Compensation Committee Charter 39.5 KB
Compensation Committee Charter 39.5 KB
Nominating and Corporate Governance Committee Charter 32.2 KB
Nominating and Corporate Governance Committee Charter 32.2 KB
Code of Business Conduct and Ethics 52.4 KB
Code of Business Conduct and Ethics 52.4 KB

Shareholder Tools

Printed Materials
Email Alerts
Download Library
RSS News Feeds
Print Page
Share
Search

  • Facebook
  • LinkedIn
  • Twitter
  • RSS

© 2023 Fate Therapeutics | 3535 General Atomics Court, Suite 200, San Diego 92121 | 866.875.1833 | LEGAL

MENU
  • About Us
    • Our Mission
    • Our Cells of Interest
    • Management
    • Board of Directors
  • Pipeline
    • Overview
    • Immuno-Oncology Candidates
      • FT500
      • FT516
      • FT596
      • FT538
      • FT576
      • FT819
    • Immuno-Regulation Candidates
      • ProTmune™
      • FT301
  • Science
    • Ex Vivo Cell Modulation
    • iPSC Platform
    • Manufacturing
    • Publications
  • Collaborations
  • Join Our Team
    • Vision, Mission, Values
    • Working at Fate
    • Career Opportunities
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
      • Historic Stock Lookup
    • Investors FAQs
  • Contact